Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.TA)

TEVA.TA on Tel Aviv Stock Exchange

4,076.00ILa
23 May 2019
Change (% chg)

-128.00 (-3.04%)
Prev Close
4,204.00
Open
4,160.00
Day's High
4,175.00
Day's Low
4,076.00
Volume
672,389
Avg. Vol
748,511
52-wk High
9,475.00
52-wk Low
4,006.00

About

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic... (more)

Overall

Beta: 1.24
Market Cap(Mil.): ₪65,841.12
Shares Outstanding(Mil.): 1,014.36
Dividend: 30.51
Yield (%): 6.31

Financials

  TEVA.TA Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -21.22 -- --
ROI: -10.61 14.23 13.82
ROE: -24.14 15.46 15.24

J&J, Teva lose last-minute bid to escape Oklahoma opioid lawsuit

An Oklahoma judge on Monday cleared the way for Johnson & Johnson and Teva Pharmaceutical Industries Ltd to face trial at the end of May in a lawsuit by the state's attorney general accusing the drugmakers of helping fuel the opioid epidemic.

May 13 2019

Teva Pharm CFO says company did not conspire to fix prices

JERUSALEM Teva Pharmaceutical Industries' chief financial officer on Sunday reiterated that the company has done nothing wrong in the wake of a price-fixing lawsuit filed by 44 U.S. states.

May 12 2019

Teva Pharm CFO says company did not conspire to fix prices

JERUSALEM, May 12 Teva Pharmaceutical Industries' chief financial officer on Sunday reiterated that the company has done nothing wrong in the wake of a price-fixing lawsuit filed by 44 U.S. states.

May 12 2019

U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit

WASHINGTON U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices - sometimes by more than 1,000% - and stifle competition for generic drugs, state prosecutors said on Saturday.

May 11 2019

UPDATE 2-U.S. states accuse Teva, other drugmakers, of price-fixing -lawsuit

WASHINGTON, May 11 U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices - sometimes by more than 1,000% - and stifle competition for generic drugs, state prosecutors said on Saturday.

May 11 2019

U.S. states sue Teva, 19 other drug companies in price-fixing complaint

WASHINGTON, May 11 Forty-four U.S. states have filed a lawsuit accusing 20 drug companies including Teva Pharmaceuticals USA Inc of a sweeping scheme to inflate drug prices and stifle competition for more than 100 generic drugs, state prosecutors said on Saturday.

May 11 2019

Teva's new migraine drug helps to contain profit fall

TEL AVIV Israel-based Teva Pharmaceutical Industries Ltd on Thursday forecast a sharp rise in revenue next year from its new migraine drug Ajovy and reported a slightly smaller-than-expected drop in first-quarter profit.

May 02 2019

UPDATE 3-Teva's new migraine drug helps to contain profit fall

* Company reiterates 2019 outlook (Adds details on EpiPen, updates share price)

May 02 2019

Israel's Teva Pharm Q1 profit falls slightly less than forecast

TEL AVIV, May 2 Israel-based Teva Pharmaceutical Industries reported a slightly smaller-than-expected drop in first-quarter profit on Thursday and said it was on track to cut $3 billion of costs by the end of 2019.

May 02 2019

Teva says Intuniv antitrust plaintiffs 'inappropriately' hired its experts

Teva Pharmaceutical Industries Ltd is seeking to disqualify two expert witnesses hired by plaintiffs who are accusing one of the drugmaker's units of illegally delaying the release of a generic version of the ADHD drug Intuniv, saying they previously testified for the company.

Apr 29 2019

Earnings vs. Estimates